Adaptimmune Therapeutics
ADAP
#9234
Rank
โ‚ฌ64.26 M
Marketcap
0,24ย โ‚ฌ
Share price
4.45%
Change (1 day)
-77.43%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -โ‚ฌ61.86 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.17 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ98.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ57.05 Million-41.87%
2023 -โ‚ฌ98.13 Million-30.65%
2022 -โ‚ฌ0.15 Billion-0.36%
2021 -โ‚ฌ0.15 Billion21.62%
2020 -โ‚ฌ0.12 Billion-4.55%
2019 -โ‚ฌ0.13 Billion69%
2018 -โ‚ฌ72.39 Million-7.47%
2017 -โ‚ฌ78.23 Million24.71%
2016 -โ‚ฌ62.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.14 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.65 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.23 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ0.59 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA